DIAMANTE s.r.l. Società Benefit

info@diamante.tech

FINANCE

BUSINESS MODEL

B2B - Revenue License model

Protocols set up and pre-clinical Studies (animal)

2024

IND enabling studies in animal models for human trials

2025

Phase 1 clinical trial in human

2026

Expected revenue

License Agreement with a Pharma Company for the Co-development of Phase 2 Clinical Studies in Human